331.25
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $331.25, with a volume of 1.60M.
It is up +0.93% in the last 24 hours and down -5.59% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$328.20
Open:
$329.24
24h Volume:
1.60M
Relative Volume:
1.87
Market Cap:
$23.31B
Revenue:
$3.22B
Net Income/Loss:
$542.70M
P/E Ratio:
44.28
EPS:
7.4805
Net Cash Flow:
$458.00M
1W Performance:
-5.98%
1M Performance:
-5.59%
6M Performance:
+37.72%
1Y Performance:
+25.71%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services Inc
|
331.25 | 23.10B | 3.22B | 542.70M | 458.00M | 7.4805 |
|
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
WST Maintains Rating by Evercore ISI Group -- Price Target Raised to $425 - GuruFocus
WEST PHARMACEUTICAL SERVICES INC : EVERCORE ISI RAISES TARGET PRICE TO $425 FROM $410 - Bitget
BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating - marketscreener.com
Weiss Asset Management LP Invests $1.99 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Renaissance Technologies LLC Has $52.55 Million Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical stock trades near record levels as injectable packaging demand supports growth - Ad-hoc-news.de
Arrowstreet Capital Limited Partnership Purchases 210,112 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia - MarketBeat
West Pharmaceutical stock holds recent gains as investors weigh steady growth and guidance - AD HOC NEWS
West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan - Yahoo Finance UK
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
ETFs Investing in West Pharmaceutical Services, Inc. Stocks - TradingView
West Pharmaceutical Services, Inc. Revenue Breakdown – MIL:1WST - TradingView
What Does Eric Green's Retirement Mean for West Pharmaceutical Services - Kavout | AI
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock trades steady as investors digest stronger 2025 guidance and recent margin - AD HOC NEWS
West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV - MarketBeat
Epoch Investment Partners Inc. Acquires 39,745 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services Inc (WST) a Bargain After 7.7% D - GuruFocus
West Pharmaceutical Services (WST) Receives a Buy from Barclays - The Globe and Mail
West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical lifts guidance on HVP-driven surge - The Globe and Mail
West Pharmaceutical Services, Inc. (WST) Earnings Dates, Call Summary & Reports - TipRanks
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - Yahoo Finance
West Pharmaceutical Services, Inc. (WPS) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Securities Class Action Lawsuit Filed Against West Pharmaceutical - The National Law Review
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (WST) and Thermo Fisher (TMO) - The Globe and Mail
West Pharmaceutical Services, Inc. (WPS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Slides as Investors Digest a Post-Earnings Surge - Quiver Quantitative
West Pharmaceutical Services Q2 2026 Earnings: Revenue, Net Income, and Financial Highlights - Minichart
Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $410 - Moomoo
WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook - Yahoo Finance
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating - marketscreener.com
West Pharmaceutical beats 2Q26 estimates, raises full-year sales and EPS guidance. - Pluang
West Pharmaceutical Delivers Another BeatBut The Real Story Is The Mix Shift (NYSE:WST) - Seeking Alpha
Sei Investments Co. Has $132.65 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical: Q2 Earnings Snapshot - theheraldreview.com
West Pharmaceutical Earnings: Another Strong Quarter and Upward Guidance Revision - Morningstar
West Pharmaceutical Services Inc. Stock Slips 7.7%, Underperforms Peers - Bitget
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical stock trades steady as recent earnings highlight margin resilience - Ad-hoc-news.de
West Pharmaceutical Services, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:WST) 2026-07-24 - Seeking Alpha
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):